Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Antimalarial alkaloid compounds available for licensing from NIH

Jan. 4, 1999

Development of new beta-lactamase inhibitors revealed by Japanese laboratories

Dec. 30, 1998

Dura and Bristol-Myers Squibb sign exclusive license agreement

Dec. 28, 1998

Miltefosine evaluated clinically for the oral treatment of visceral leishmaniasis

Dec. 22, 1998

Novel antiviral nucleoside analogues from Glaxo Wellcome, U. Michigan

Dec. 18, 1998

Macrolactam monosaccharide of microbial origin with antifungal and antibacterial activity

Dec. 18, 1998

Itraconazole prevents relapse of P. marneffei infection in HIV-infected patients

Dec. 17, 1998

Meiji Seika describes carbapenems with potent, broad-spectrum activity

Dec. 17, 1998

Agouron initiates human testing of antirhinoviral agent AG-7088

Dec. 17, 1998

TerraGen and Schering-Plough Research Institute establish collaborative agreement

Dec. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...